Pharmaceutical Supply – Adenosine Injection (NSN: 6505015303307)

The contract entails the supply of one unit of Adenosine Injection, a sterile pharmaceutical product intended for cardiac use, adhering strictly to FDA, USP, and Department of Defense medical standards. The product is identified by National Stock Number 6505015303307 and will be delivered FOB destination to a U.S. Navy vessel, ensuring compliance with military logistics and medical requirements. The contract falls under NAICS code 325412, classifying it within the pharmaceutical and medicine manufacturing sector, and is issued as a subcontract by the Defense Logistics Agency under the Department of Defense. The award was posted on July 15, 2026, and the transaction is tracked through the DIBBS system with contract and delivery identifiers, indicating formal procurement alignment with DOD supply chain protocols.